{"gene":"AP2M1","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":1988,"finding":"AP50 (AP2M1) was molecularly cloned and identified as the 50 kDa medium-chain protein component of the clathrin-coated vesicle coat assembly protein complex AP-2, encoding a 435 amino acid polypeptide of 49,612 Da that is highly conserved between rat and bovine brain.","method":"Molecular cloning and amino acid sequencing from rat brain cDNA libraries","journal":"DNA (Mary Ann Liebert, Inc.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct molecular cloning and full sequence determination; foundational characterization replicated across species","pmids":["3148444"],"is_preprint":false},{"year":1993,"finding":"AP50 (AP2M1) is phosphorylated in vivo and in vitro at a single site, Thr-156, by an AP50 kinase activity that co-purifies with the AP complex (AP-1 and a soluble ~280 kDa protein complex); AP50 itself cannot autophosphorylate.","method":"In vitro phosphorylation, tryptic peptide mapping, automated Edman degradation, synthetic peptide substrate assay, gel filtration","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed identification by peptide sequencing and Edman degradation, multiple orthogonal biochemical methods in one study","pmids":["8257432"],"is_preprint":false},{"year":1995,"finding":"The human CLAPM1 (AP2M1) gene maps to chromosome region 3q28 by chromosomal in situ hybridization.","method":"Chromosomal fluorescence in situ hybridization (FISH) of a human genomic clone","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct FISH mapping; single lab, single method but definitive chromosomal localization","pmids":["8595912"],"is_preprint":false},{"year":1997,"finding":"AP2M1 (AP50), the medium chain of AP-2, directly binds the cytoplasmic domain of CTLA-4 via the YXXΦ motif (GVYVKM, residues 199–204); mutation of Y201 abrogates binding and causes accumulation of CTLA-4 at the cell surface, demonstrating that AP2M1 mediates ligand-independent endocytosis of CTLA-4 into clathrin-coated vesicles.","method":"Yeast two-hybrid, co-immunoprecipitation, cell surface expression assay, site-directed mutagenesis (Y201 mutation)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal yeast two-hybrid and Co-IP with mutagenesis, replicated across two independent labs in the same year","pmids":["9200449","9256472"],"is_preprint":false},{"year":1997,"finding":"Phosphorylation of CTLA-4 Y201 abolishes its binding to AP2M1 (AP50) and instead enables binding to the p85 subunit of PI3K (and weakly to SHP-2/SHP-1), demonstrating that the phosphorylation status of the YXXΦ motif determines which downstream effector is recruited.","method":"Yeast two-hybrid, co-immunoprecipitation in 293T cells, CTLA-4 phosphopeptide vs. unphosphorylated peptide binding assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct peptide-binding assay with phosphorylated vs. unphosphorylated forms plus Co-IP and yeast two-hybrid, replicated finding across two concurrent papers","pmids":["9256472","9200449"],"is_preprint":false},{"year":1999,"finding":"The Drosophila ortholog of AP2M1 (AP50) is 86% identical to mouse and human AP2M1, is encoded by a single-copy gene at polytene chromosome position 94B1-B2, and is highly expressed in the central nervous system and midgut caecum during embryogenesis, consistent with conserved function in clathrin-mediated endocytosis in neurons.","method":"EST database identification, cDNA cloning, polytene chromosome mapping, in situ hybridization","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sequence identity and expression mapping establish ortholog status; functional inference based on sequence conservation","pmids":["10375633"],"is_preprint":false},{"year":2003,"finding":"AP2M1 (AP50) binds the cytoplasmic domain of B cell co-receptor CD22 via tyrosine-based internalization motifs; Tyr843 constitutes the primary binding site, and either Tyr843 or Tyr863 is sufficient for mAb-mediated internalization of CD22 via the AP-2 complex.","method":"Yeast two-hybrid, co-immunoprecipitation (co-precipitation of alpha-adaptin), transfectant Jurkat cell internalization assays with wild-type and mutant CD22","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus Co-IP plus functional endocytosis assay with mutagenesis, multiple orthogonal methods in one study","pmids":["12646615"],"is_preprint":false},{"year":2008,"finding":"AP2M1 (AP50) binds the alpha1b-adrenergic receptor (alpha1b-AR) via a YXXΦ motif in its C-tail; the alpha1a-AR does not bind AP50. Phosphorylation sites in the alpha1b-AR C-tail are required for beta-arrestin interaction (the dominant endocytic trigger), while AP50 binding alone is insufficient to drive efficient internalization.","method":"Co-immunoprecipitation, beta-arrestin translocation assays, biotinylation experiments, confocal microscopy, RNA interference","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, RNAi, live imaging, biotinylation) in one study with clear mechanistic dissection","pmids":["18523139"],"is_preprint":false},{"year":2012,"finding":"A conserved YXXΦ motif in HCV core protein mediates direct binding to AP2M1; this interaction recruits AP2M1 to lipid droplets, promotes core trafficking away from lipid droplets toward the trans-Golgi network, and is essential for viral assembly but not RNA replication. AAK1 and GAK kinases, which phosphorylate AP2M1 at Thr156, stimulate core–AP2M1 binding and are required for HCV assembly.","method":"Microfluidics affinity analysis, protein-fragment complementation assay, co-immunoprecipitation in infected cells, YXXΦ mutagenesis, AP2M1 siRNA knockdown, dominant-negative AP2M1 overexpression, quantitative confocal immunofluorescence, pharmacological kinase inhibition","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods including complementation assay, Co-IP, mutagenesis, dominant-negative, and KD, all in infected cells","pmids":["22916011"],"is_preprint":false},{"year":2018,"finding":"AP2M1 is identified as a downstream target of the cdk4–EZH2 axis during chemotherapy-induced senescence; AP2M1 is involved in transmission of secreted signals from senescent cells (likely via receptor endocytosis), and its upregulation by EZH2 facilitates escape from senescence in colorectal/breast cancer cells.","method":"Quantitative proteomic analysis, siRNA knockdown of EZH2, pharmacological EZH2 inhibition, cell emergence assay","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — proteomics identification with functional siRNA/inhibitor follow-up; mechanism proposed but partially validated","pmids":["29415991"],"is_preprint":false},{"year":2019,"finding":"A recurrent de novo p.Arg170Trp variant in AP2M1 impairs the conformational activation of the AP-2 complex and significantly reduces clathrin-mediated endocytosis of transferrin in human cells and in astrocytes from AP-2μ conditional knockout mice, without affecting AP2M1 stability, expression, membrane recruitment, or localization.","method":"Whole-exome sequencing, protein dynamics modeling, functional complementation of p.Arg170Trp in human cells, transferrin endocytosis assay in AP-2μ conditional KO mouse astrocytes","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional complementation in human cells and mouse primary astrocytes with quantified endocytosis assay, supported by structural modeling; multiple orthogonal approaches","pmids":["31104773"],"is_preprint":false},{"year":2020,"finding":"AP2M1 is exploited by multiple viruses (influenza A, ZIKV, HIV, MERS-CoV, SARS-CoV-2, enterovirus A71) through their conserved YXXΦ motifs; AP2M1 depletion or YXXΦ mutation causes incorrect localization of viral proteins (e.g., failure of IAV nucleoprotein nuclear import, loss of ER localization of ZIKV-NS3), suppressing viral replication. The small molecule ACA disrupts AP2M1–virus interactions and inhibits viral replication in vitro and in vivo.","method":"YxxΦ mutagenesis of viral proteins, AP2M1 siRNA depletion, pharmacological inhibition (ACA compound), immunofluorescence localization, in vitro and in vivo antiviral assays across multiple virus types","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple viruses, multiple orthogonal methods (mutagenesis, KD, pharmacology, localization), both in vitro and in vivo","pmids":["32923629"],"is_preprint":false},{"year":2021,"finding":"AP2M1 mediates autophagy-induced clathrin-dependent endocytosis and lysosomal degradation of the tight junction protein CLDN2 (claudin-2). AP2M1 binds CLDN2 via YXXΦ motifs (residues 67–70 and 148–151), and increased AP2M1 phosphorylation upon starvation promotes CLDN2-LC3 interaction. AP2M1 knockout prevents autophagy-induced CLDN2 degradation and enhances intestinal TJ permeability.","method":"Co-immunoprecipitation, immunolocalization, membrane fractionation, pharmacological inhibition of clathrin-mediated endocytosis, site-directed mutagenesis of CLDN2 YXXΦ motifs, AP2M1 CRISPR knockout, in vitro (cell lines), in vivo (mouse colon), ex vivo (human colon)","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, CRISPR KO, mutagenesis, fractionation, in vivo mouse, ex vivo human tissue), single lab but highly comprehensive","pmids":["34964704"],"is_preprint":false},{"year":2021,"finding":"AP2M1 (dpy-23 in C. elegans) supports TGF-β signaling for collagen expression by limiting caveolin-1 (CAV-1) expression; loss of dpy-23/AP2M1 upregulates cav-1 in hypodermis, which increases clathrin-independent endocytosis and reduces TGF-β receptor I (TβRI) levels, thereby reducing TGF-β signaling and collagen production.","method":"C. elegans suppressor screen, RNA-seq, cav-1 RNAi knockdown, genetic epistasis (dpy-23 × lon-2 double mutant)","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with RNA-seq and RNAi in C. elegans ortholog; indirect pathway placement for mammalian AP2M1","pmids":["33561975"],"is_preprint":false},{"year":2021,"finding":"AP2M1 interacts with the planar cell polarity protein Vangl2 at both its N-terminus and C-terminal Prickle-binding domain; knockdown of AP2M1 in developing cortical neurons reduces dendritic branching similarly to Vangl2 knockdown, establishing AP2M1-mediated endocytosis as necessary for dendrite morphogenesis.","method":"Yeast two-hybrid screen from mouse brain lysate, pull-down assay, shRNA knockdown in cortical neurons with dendritic branching quantification","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid confirmed by pull-down, functional KD phenotype replicated for both Vangl2 and AP2M1; single lab","pmids":["34626136"],"is_preprint":false},{"year":2021,"finding":"LRRK2 directly binds and phosphorylates AP2M1 (μ2 subunit of AP-2); loss of LRRK2 reduces AP2M1 phosphorylation (required for initial clathrin-coated vesicle formation), while overexpression or gain-of-function LRRK2 G2019S inhibits CCV uncoating at later stages, blocking new CCV formation cycles. LRRK2-dependent AP2M1 phosphorylation is brain-specific and mediates dopaminergic neurodegeneration in a Drosophila PD model.","method":"Kinase binding and phosphorylation assays, analysis of SH-SY5Y cells, mouse neurons and tissues (LRRK2 KO and G2019S knockin), Drosophila genetic model of PD with neurodegeneration readout","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct kinase–substrate relationship demonstrated in multiple cell/tissue systems and confirmed functionally in vivo (Drosophila), multiple orthogonal methods","pmids":["34315807"],"is_preprint":false},{"year":2025,"finding":"In a Drosophila model of AP2M1-DEE, pan-neuronal RNAi knockdown of the AP-2μ ortholog causes heat-sensitive paralysis and altered class IV dendritic arborization neuron morphology; a CRISPR-engineered p.Arg170Trp fly shows a milder seizure-resistant phenotype, suggesting the epilepsy in AP2M1-DEE may arise from broader neuronal developmental defects rather than direct synaptic dysfunction.","method":"Pan-neuronal RNAi, CRISPR knock-in of p.Arg170Trp, Drosophila behavioral assays (heat-sensitive paralysis, electrically induced seizures), dendritic morphology analysis","journal":"Disease models & mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR-engineered disease variant in Drosophila with multiple phenotypic readouts; single lab, ortholog model","pmids":["41017589"],"is_preprint":false},{"year":2026,"finding":"In APP-overexpressing neurons, GluA2 (AMPAR subunit) undergoes enhanced endocytosis driven by increased interaction with AP2M1; a competitive peptide (G2CT) targeting the GluA2–AP2M1 interaction restores GluA2 membrane expression, improves synaptic function in vivo, and rescues cognitive deficits in 5×FAD mice without altering amyloid processing.","method":"Co-immunoprecipitation, surface biotinylation, competitive peptide (G2CT) treatment, in vivo electrophysiology, behavioral cognitive testing in 5×FAD mice, human AD brain tissue validation","journal":"Neuropharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP plus competitive peptide intervention with both in vitro and in vivo functional rescue in disease model and human tissue validation","pmids":["41740904"],"is_preprint":false},{"year":2026,"finding":"NAK family kinases (AAK1, GAK, BMP2K) phosphorylate AP2M1 at Thr156, activating AP2M1 and promoting its interaction with the YXXΦ motif in PRRSV glycoprotein GP5 and the receptor CD163, which is critical for efficient PRRSV trafficking to early endosomes; disruption of this phosphorylation or blockade of the AP2M1–YXXΦ interaction significantly impairs PRRSV internalization.","method":"Genetic (siRNA/CRISPR) and pharmacological inhibition of AAK1/GAK/BMP2K, AP2M1 phosphorylation site mutagenesis (Thr156), co-immunoprecipitation, viral entry/trafficking assays","journal":"Transboundary and emerging diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct phosphorylation-site mutagenesis at Thr156, genetic and pharmacological approaches with mechanistic Co-IP, functional viral entry readout","pmids":["41982333"],"is_preprint":false}],"current_model":"AP2M1 encodes the μ2 (medium) subunit of the clathrin adaptor protein complex AP-2 and functions as the primary cargo-recognition module: its binding domain engages YXXΦ internalization motifs in diverse transmembrane cargo proteins (CTLA-4, CD22, alpha1b-AR, CLDN2, GluA2, and viral proteins), directing them into clathrin-coated vesicles; this activity is regulated by phosphorylation of Thr156 by AAK1/GAK/LRRK2-family kinases (activating cargo binding) and by dephosphorylation during CCV uncoating (enabling coat recycling), while a pathogenic p.Arg170Trp variant impairs AP-2 conformational activation and reduces clathrin-mediated endocytosis, causing developmental and epileptic encephalopathy."},"narrative":{"mechanistic_narrative":"AP2M1 encodes the μ2 (medium, ~50 kDa) chain of the clathrin adaptor protein complex AP-2 and serves as the principal cargo-recognition module of clathrin-mediated endocytosis [PMID:3148444]. Its binding domain directly engages tyrosine-based YXXΦ internalization motifs in the cytoplasmic tails of diverse transmembrane cargo, including the immune receptors CTLA-4 [PMID:9200449, PMID:9256472] and CD22 [PMID:12646615], the α1b-adrenergic receptor [PMID:18523139], the tight-junction protein claudin-2 [PMID:34964704], and the AMPA-receptor subunit GluA2 [PMID:41740904], directing these proteins into clathrin-coated vesicles. Cargo selectivity is gated by phosphorylation: for CTLA-4, phosphorylation of the YXXΦ tyrosine abolishes AP2M1 binding and instead recruits PI3K, switching the receptor between endocytic and signaling fates [PMID:9256472, PMID:9200449]. AP2M1 activity is itself controlled by phosphorylation at Thr156 by NAK-family kinases (AAK1, GAK, BMP2K) and by LRRK2, which activates cargo engagement and licenses coat assembly [PMID:8257432, PMID:34315807, PMID:41982333]; LRRK2 gain-of-function additionally impairs vesicle uncoating [PMID:34315807]. Numerous viruses subvert this machinery by presenting their own YXXΦ motifs to AP2M1 to drive assembly, entry, and intracellular trafficking, including HCV core [PMID:22916011], PRRSV GP5/CD163 [PMID:41982333], and a broad panel of RNA viruses whose replication depends on AP2M1 [PMID:32923629]. AP2M1-dependent endocytosis is required for neuronal development, supporting Vangl2-mediated dendrite morphogenesis [PMID:34626136], and a recurrent de novo p.Arg170Trp variant that blocks AP-2 conformational activation and reduces clathrin-mediated endocytosis causes developmental and epileptic encephalopathy [PMID:31104773].","teleology":[{"year":1988,"claim":"Established the molecular identity of AP2M1 by cloning the 50 kDa medium chain of the AP-2 coat complex, defining the protein whose function would later be dissected.","evidence":"Molecular cloning and full amino-acid sequencing from rat brain cDNA","pmids":["3148444"],"confidence":"High","gaps":["Sequence alone did not reveal the cargo-binding function","No structural or regulatory mechanism defined at this stage"]},{"year":1993,"claim":"Identified Thr156 as the single regulatory phosphorylation site on AP2M1, targeted by an associated kinase activity rather than autophosphorylation, establishing post-translational control of the subunit.","evidence":"In vitro phosphorylation, tryptic peptide mapping and Edman degradation","pmids":["8257432"],"confidence":"High","gaps":["Identity of the responsible kinase(s) not established","Functional consequence of Thr156 phosphorylation for cargo binding not yet shown"]},{"year":1997,"claim":"Demonstrated that AP2M1 directly recognizes YXXΦ motifs in cargo, using CTLA-4, and that phosphorylation of the cargo tyrosine acts as a binary switch between AP2M1-mediated endocytosis and PI3K signaling.","evidence":"Yeast two-hybrid, Co-IP, surface expression assays, and phospho- vs non-phosphopeptide binding with Y201 mutagenesis","pmids":["9200449","9256472"],"confidence":"High","gaps":["Generality of the YXXΦ recognition across cargo not yet established","Structural basis of the phospho-switch not resolved"]},{"year":2003,"claim":"Extended the cargo-recognition model to CD22, showing AP2M1-mediated internalization is a general mechanism for receptor downregulation via tyrosine motifs.","evidence":"Yeast two-hybrid, Co-IP of α-adaptin, and internalization assays with cargo mutants","pmids":["12646615"],"confidence":"High","gaps":["Quantitative contribution of each tyrosine motif in vivo unclear","Did not address regulation by AP2M1 phosphorylation"]},{"year":2008,"claim":"Showed that AP2M1 binding to cargo (α1b-AR) can be necessary but insufficient for efficient internalization, positioning AP2M1 within a multi-adaptor system that includes β-arrestin.","evidence":"Co-IP, β-arrestin translocation, biotinylation, confocal imaging and RNAi","pmids":["18523139"],"confidence":"High","gaps":["Hierarchy between AP2M1 and arrestin adaptors not generalized","Did not define receptor classes requiring AP2M1 alone"]},{"year":2012,"claim":"Linked AP2M1 Thr156 phosphorylation by AAK1/GAK to active cargo engagement, demonstrated for HCV core, connecting the 1993 phospho-site to functional cargo binding.","evidence":"Affinity analysis, complementation assay, Co-IP in infected cells, mutagenesis, siRNA, dominant-negative and kinase inhibition","pmids":["22916011"],"confidence":"High","gaps":["Whether host cargo (not viral) is similarly gated by Thr156 not directly tested here","Structural mechanism of phospho-activation unresolved"]},{"year":2018,"claim":"Placed AP2M1 downstream of the cdk4–EZH2 axis in chemotherapy-induced senescence, implicating its endocytic activity in intercellular senescence signaling and escape.","evidence":"Quantitative proteomics, EZH2 siRNA/inhibition, and cell emergence assays","pmids":["29415991"],"confidence":"Medium","gaps":["Direct endocytic cargo mediating senescence signals not identified","Mechanism inferred rather than reconstituted"]},{"year":2019,"claim":"Defined AP2M1 as a human disease gene by showing a recurrent de novo p.Arg170Trp variant impairs AP-2 conformational activation and clathrin-mediated endocytosis, causing developmental and epileptic encephalopathy.","evidence":"Exome sequencing, dynamics modeling, complementation in human cells and transferrin endocytosis in AP-2μ conditional-KO mouse astrocytes","pmids":["31104773"],"confidence":"High","gaps":["Cell types and circuits driving epilepsy not defined","How reduced endocytosis produces the neurological phenotype unresolved"]},{"year":2020,"claim":"Generalized AP2M1 as a broadly exploited host factor across RNA viruses via their YXXΦ motifs, and showed pharmacological disruption of these interactions is antiviral.","evidence":"YXXΦ mutagenesis, siRNA depletion, ACA small-molecule inhibition, localization and in vitro/in vivo antiviral assays across multiple viruses","pmids":["32923629"],"confidence":"High","gaps":["Whether ACA also impairs essential host endocytosis not fully resolved","Virus-specific dependencies on AP2M1 phosphorylation not dissected"]},{"year":2021,"claim":"Established LRRK2 as a direct AP2M1 kinase whose phosphorylation drives coat assembly while gain-of-function blocks uncoating, linking AP2M1 regulation to dopaminergic neurodegeneration.","evidence":"Kinase binding/phosphorylation assays in SH-SY5Y cells, LRRK2-KO and G2019S mouse tissue, and a Drosophila PD model","pmids":["34315807"],"confidence":"High","gaps":["Whether LRRK2 and NAK kinases compete or cooperate at Thr156 unclear","Brain-specificity mechanism not fully explained"]},{"year":2021,"claim":"Expanded AP2M1's physiological roles to tight-junction remodeling (autophagy-driven CLDN2 degradation), dendrite morphogenesis (Vangl2 endocytosis), and TGF-β signaling via the C. elegans ortholog.","evidence":"Co-IP, CRISPR KO, fractionation and in vivo/ex vivo tissue (CLDN2); yeast two-hybrid and shRNA in cortical neurons (Vangl2); suppressor screen and epistasis in C. elegans (TGF-β/CAV-1)","pmids":["34964704","34626136","33561975"],"confidence":"Medium","gaps":["Vangl2 and TGF-β roles rest on single-lab and ortholog evidence","Direct cargo relationships in mammalian neurons partially inferred"]},{"year":2026,"claim":"Connected AP2M1-driven cargo endocytosis to disease-relevant synaptic dysfunction, showing enhanced GluA2–AP2M1 interaction underlies AMPAR loss in Alzheimer models and that blocking it rescues cognition.","evidence":"Co-IP, surface biotinylation, competitive peptide (G2CT), in vivo electrophysiology and behavior in 5×FAD mice with human AD tissue validation","pmids":["41740904"],"confidence":"High","gaps":["Whether AP2M1 Thr156 phosphorylation modulates the GluA2 interaction not tested","Generalizability beyond amyloid models unknown"]},{"year":2026,"claim":"Confirmed that NAK-family kinases (AAK1, GAK, BMP2K) activate AP2M1 via Thr156 to promote YXXΦ cargo engagement, demonstrated for PRRSV GP5/CD163 trafficking.","evidence":"siRNA/CRISPR and pharmacological kinase inhibition, Thr156 mutagenesis, Co-IP and viral entry/trafficking assays","pmids":["41982333"],"confidence":"High","gaps":["Endogenous host cargo dependence on each NAK kinase not fully mapped","Spatial/temporal coordination with LRRK2 phosphorylation unresolved"]},{"year":null,"claim":"How AP2M1 loss-of-function and altered cargo selectivity translate into specific neurodevelopmental and neurodegenerative phenotypes — and how Thr156 phosphorylation by competing kinases is coordinated in vivo — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking endocytic deficit to circuit-level pathology","Kinase hierarchy controlling AP2M1 activation in different tissues undefined","Structural mechanism of p.Arg170Trp-induced conformational defect not solved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[3,6,7,12,17]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[3,6,8,11,18]},{"term_id":"GO:0001618","term_label":"virus receptor activity","supporting_discovery_ids":[11,18]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,3]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,7,12,17]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,3,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8,11,18]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,7,13]}],"complexes":["AP-2 adaptor complex"],"partners":["CTLA4","CD22","ADRA1B","CLDN2","GRIA2","VANGL2","LRRK2","AAK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96CW1","full_name":"AP-2 complex subunit mu","aliases":["AP-2 mu chain","Adaptin-mu2","Adaptor protein complex AP-2 subunit mu","Adaptor-related protein complex 2 subunit mu","Clathrin assembly protein complex 2 mu medium chain","Clathrin coat assembly protein AP50","Clathrin coat-associated protein AP50","HA2 50 kDa subunit","Plasma membrane adaptor AP-2 50 kDa protein"],"length_aa":435,"mass_kda":49.7,"function":"Component of the adaptor protein complex 2 (AP-2) (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis (PubMed:16581796). AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface (PubMed:12694563, PubMed:12952941, PubMed:14745134, PubMed:14985334, PubMed:15473838, PubMed:31104773). AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules (By similarity). AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway (PubMed:19033387). During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 mu subunit binds to transmembrane cargo proteins; it recognizes the Y-X-X-Phi motifs (By similarity). The surface region interacting with to the Y-X-X-Phi motif is inaccessible in cytosolic AP-2, but becomes accessible through a conformational change following phosphorylation of AP-2 mu subunit at Thr-156 in membrane-associated AP-2 (PubMed:11877457). The membrane-specific phosphorylation event appears to involve assembled clathrin which activates the AP-2 mu kinase AAK1 (PubMed:11877457). Plays a role in endocytosis of frizzled family members upon Wnt signaling (By similarity)","subcellular_location":"Cell membrane; Membrane, coated pit","url":"https://www.uniprot.org/uniprotkb/Q96CW1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/AP2M1","classification":"Common Essential","n_dependent_lines":934,"n_total_lines":1208,"dependency_fraction":0.7731788079470199},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"AP2B1","stoichiometry":10.0},{"gene":"AP2S1","stoichiometry":10.0},{"gene":"EPS15","stoichiometry":4.0},{"gene":"NECAP2","stoichiometry":4.0},{"gene":"RALBP1","stoichiometry":4.0},{"gene":"AHSA1","stoichiometry":0.2},{"gene":"ANKRD28","stoichiometry":0.2},{"gene":"CLTA","stoichiometry":0.2},{"gene":"CLTB","stoichiometry":0.2},{"gene":"ITSN1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/AP2M1","total_profiled":1310},"omim":[{"mim_id":"618587","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES; MRD60","url":"https://www.omim.org/entry/618587"},{"mim_id":"616405","title":"ADAPTOR PROTEIN 2-ASSOCIATED KINASE 1; AAK1","url":"https://www.omim.org/entry/616405"},{"mim_id":"612453","title":"MULTIPLE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS 10; MEGF10","url":"https://www.omim.org/entry/612453"},{"mim_id":"610469","title":"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2","url":"https://www.omim.org/entry/610469"},{"mim_id":"610366","title":"ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1","url":"https://www.omim.org/entry/610366"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/AP2M1"},"hgnc":{"alias_symbol":["AP50","mu2"],"prev_symbol":["CLAPM1"]},"alphafold":{"accession":"Q96CW1","domains":[{"cath_id":"3.30.450.60","chopping":"3-124","consensus_level":"high","plddt":92.602,"start":3,"end":124},{"cath_id":"2.60.40.1170","chopping":"171-226_239-282_394-432","consensus_level":"high","plddt":92.0249,"start":171,"end":432},{"cath_id":"2.60.40.1170","chopping":"287-391","consensus_level":"high","plddt":93.0357,"start":287,"end":391}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CW1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CW1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CW1-F1-predicted_aligned_error_v6.png","plddt_mean":89.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AP2M1","jax_strain_url":"https://www.jax.org/strain/search?query=AP2M1"},"sequence":{"accession":"Q96CW1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96CW1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96CW1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CW1"}},"corpus_meta":[{"pmid":"9200449","id":"PMC_9200449","title":"Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9200449","citation_count":167,"is_preprint":false},{"pmid":"9256472","id":"PMC_9256472","title":"Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9256472","citation_count":136,"is_preprint":false},{"pmid":"22916011","id":"PMC_22916011","title":"Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.","date":"2012","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/22916011","citation_count":129,"is_preprint":false},{"pmid":"31104773","id":"PMC_31104773","title":"A Recurrent Missense Variant in AP2M1 Impairs Clathrin-Mediated Endocytosis and Causes Developmental and Epileptic Encephalopathy.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31104773","citation_count":96,"is_preprint":false},{"pmid":"17290396","id":"PMC_17290396","title":"Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17290396","citation_count":92,"is_preprint":false},{"pmid":"34964704","id":"PMC_34964704","title":"AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34964704","citation_count":78,"is_preprint":false},{"pmid":"32923629","id":"PMC_32923629","title":"Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32923629","citation_count":53,"is_preprint":false},{"pmid":"29415991","id":"PMC_29415991","title":"Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapy.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29415991","citation_count":51,"is_preprint":false},{"pmid":"3148444","id":"PMC_3148444","title":"Molecular cloning and complete amino acid sequence of AP50, an assembly protein associated with clathrin-coated vesicles.","date":"1988","source":"DNA (Mary Ann Liebert, Inc.)","url":"https://pubmed.ncbi.nlm.nih.gov/3148444","citation_count":45,"is_preprint":false},{"pmid":"18523139","id":"PMC_18523139","title":"Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.","date":"2008","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18523139","citation_count":43,"is_preprint":false},{"pmid":"12646615","id":"PMC_12646615","title":"The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12646615","citation_count":39,"is_preprint":false},{"pmid":"34315807","id":"PMC_34315807","title":"Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration.","date":"2021","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34315807","citation_count":33,"is_preprint":false},{"pmid":"8257432","id":"PMC_8257432","title":"The 50 kDa protein subunit of assembly polypeptide (AP) AP-2 adaptor from clathrin-coated vesicles is phosphorylated on threonine-156 by AP-1 and a soluble AP50 kinase which co-purifies with the assembly polypeptides.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8257432","citation_count":29,"is_preprint":false},{"pmid":"36468008","id":"PMC_36468008","title":"Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer's disease.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36468008","citation_count":24,"is_preprint":false},{"pmid":"2061618","id":"PMC_2061618","title":"Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50).","date":"1991","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/2061618","citation_count":24,"is_preprint":false},{"pmid":"822131","id":"PMC_822131","title":"Characteristics of phage AP50, an RNA phage containing phospholipids.","date":"1976","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/822131","citation_count":20,"is_preprint":false},{"pmid":"32943990","id":"PMC_32943990","title":"Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemia.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32943990","citation_count":18,"is_preprint":false},{"pmid":"10375633","id":"PMC_10375633","title":"Cloning, mapping and tissue-specific expression of Drosophila clathrin-associated protein AP50 gene.","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10375633","citation_count":9,"is_preprint":false},{"pmid":"8595912","id":"PMC_8595912","title":"Chromosome localization of human genes for clathrin adaptor polypeptides AP2 beta and AP50 and the clathrin-binding protein, VCP.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8595912","citation_count":9,"is_preprint":false},{"pmid":"39818381","id":"PMC_39818381","title":"AP2M1 as the potential biomarker for prediction of the response of atopic dermatitis to Dupilumab therapy: Multi-omics analysis and evidence.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39818381","citation_count":6,"is_preprint":false},{"pmid":"33561975","id":"PMC_33561975","title":"AP2M1 Supports TGF-β Signals to Promote Collagen Expression by Inhibiting Caveolin Expression.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33561975","citation_count":5,"is_preprint":false},{"pmid":"34626136","id":"PMC_34626136","title":"Planar cell polarity protein Vangl2 and its interacting protein Ap2m1 regulate dendritic branching in cortical neurons.","date":"2021","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/34626136","citation_count":4,"is_preprint":false},{"pmid":"41082341","id":"PMC_41082341","title":"AP2M1 Amplification Orchestrates Notch-Mediated Chemoresistance in Hematopoietic Stem Cells of Acute Myeloid Leukemia Patients.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41082341","citation_count":2,"is_preprint":false},{"pmid":"40631915","id":"PMC_40631915","title":"AP2M1 Is a Candidate Gene for Microcephaly and Intellectual Disability in 3q27.1 Deletions.","date":"2025","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/40631915","citation_count":2,"is_preprint":false},{"pmid":"41017589","id":"PMC_41017589","title":"Modeling AP2M1 developmental and epileptic encephalopathy in Drosophila.","date":"2025","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/41017589","citation_count":1,"is_preprint":false},{"pmid":"41153917","id":"PMC_41153917","title":"Copy Number Variation and SNP Affect Egg Production in Chickens by Regulating AP2M1 Expression to Inhibit GnRH Synthesis.","date":"2025","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/41153917","citation_count":1,"is_preprint":false},{"pmid":"41982333","id":"PMC_41982333","title":"Numb-Associated Kinases-Mediated AP2M1 Activation Facilitates Porcine Reproductive and Respiratory Syndrome Virus Entry.","date":"2026","source":"Transboundary and emerging diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41982333","citation_count":0,"is_preprint":false},{"pmid":"41451492","id":"PMC_41451492","title":"[Clinical and genetic analysis of a child with intellectual developmental disorder and seizures associated with variant of AP2M1 gene].","date":"2025","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41451492","citation_count":0,"is_preprint":false},{"pmid":"41327404","id":"PMC_41327404","title":"The role of AP2M1 in oncofetal characteristics: integrative in silico, in vitro, and in vivo analyses using zebrafish models.","date":"2025","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/41327404","citation_count":0,"is_preprint":false},{"pmid":"41740904","id":"PMC_41740904","title":"Inhibiting AP2M1-mediated GluA2 endocytosis by G2CT peptide ameliorates synaptic and memory deficits in Alzheimer's Disease.","date":"2026","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41740904","citation_count":0,"is_preprint":false},{"pmid":"41696752","id":"PMC_41696752","title":"Mendelian randomization analysis identifies HLA-A and AP2M1 as genetic biomarkers linked to immune-endocytic crosstalk in intervertebral disc degeneration.","date":"2026","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/41696752","citation_count":0,"is_preprint":false},{"pmid":"34532558","id":"PMC_34532558","title":"Quantitation of Regulatory Activity for the Complement Alternative PathwayUsing an Adaptation of the AP50 in vitro Assay.","date":"2018","source":"Bio-protocol","url":"https://pubmed.ncbi.nlm.nih.gov/34532558","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18491,"output_tokens":5205,"usd":0.066774,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13594,"output_tokens":4620,"usd":0.091735,"stage2_stop_reason":"end_turn"},"total_usd":0.158509,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"AP50 (AP2M1) was molecularly cloned and identified as the 50 kDa medium-chain protein component of the clathrin-coated vesicle coat assembly protein complex AP-2, encoding a 435 amino acid polypeptide of 49,612 Da that is highly conserved between rat and bovine brain.\",\n      \"method\": \"Molecular cloning and amino acid sequencing from rat brain cDNA libraries\",\n      \"journal\": \"DNA (Mary Ann Liebert, Inc.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct molecular cloning and full sequence determination; foundational characterization replicated across species\",\n      \"pmids\": [\"3148444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"AP50 (AP2M1) is phosphorylated in vivo and in vitro at a single site, Thr-156, by an AP50 kinase activity that co-purifies with the AP complex (AP-1 and a soluble ~280 kDa protein complex); AP50 itself cannot autophosphorylate.\",\n      \"method\": \"In vitro phosphorylation, tryptic peptide mapping, automated Edman degradation, synthetic peptide substrate assay, gel filtration\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed identification by peptide sequencing and Edman degradation, multiple orthogonal biochemical methods in one study\",\n      \"pmids\": [\"8257432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The human CLAPM1 (AP2M1) gene maps to chromosome region 3q28 by chromosomal in situ hybridization.\",\n      \"method\": \"Chromosomal fluorescence in situ hybridization (FISH) of a human genomic clone\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct FISH mapping; single lab, single method but definitive chromosomal localization\",\n      \"pmids\": [\"8595912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"AP2M1 (AP50), the medium chain of AP-2, directly binds the cytoplasmic domain of CTLA-4 via the YXXΦ motif (GVYVKM, residues 199–204); mutation of Y201 abrogates binding and causes accumulation of CTLA-4 at the cell surface, demonstrating that AP2M1 mediates ligand-independent endocytosis of CTLA-4 into clathrin-coated vesicles.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, cell surface expression assay, site-directed mutagenesis (Y201 mutation)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal yeast two-hybrid and Co-IP with mutagenesis, replicated across two independent labs in the same year\",\n      \"pmids\": [\"9200449\", \"9256472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Phosphorylation of CTLA-4 Y201 abolishes its binding to AP2M1 (AP50) and instead enables binding to the p85 subunit of PI3K (and weakly to SHP-2/SHP-1), demonstrating that the phosphorylation status of the YXXΦ motif determines which downstream effector is recruited.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation in 293T cells, CTLA-4 phosphopeptide vs. unphosphorylated peptide binding assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct peptide-binding assay with phosphorylated vs. unphosphorylated forms plus Co-IP and yeast two-hybrid, replicated finding across two concurrent papers\",\n      \"pmids\": [\"9256472\", \"9200449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The Drosophila ortholog of AP2M1 (AP50) is 86% identical to mouse and human AP2M1, is encoded by a single-copy gene at polytene chromosome position 94B1-B2, and is highly expressed in the central nervous system and midgut caecum during embryogenesis, consistent with conserved function in clathrin-mediated endocytosis in neurons.\",\n      \"method\": \"EST database identification, cDNA cloning, polytene chromosome mapping, in situ hybridization\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sequence identity and expression mapping establish ortholog status; functional inference based on sequence conservation\",\n      \"pmids\": [\"10375633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"AP2M1 (AP50) binds the cytoplasmic domain of B cell co-receptor CD22 via tyrosine-based internalization motifs; Tyr843 constitutes the primary binding site, and either Tyr843 or Tyr863 is sufficient for mAb-mediated internalization of CD22 via the AP-2 complex.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation (co-precipitation of alpha-adaptin), transfectant Jurkat cell internalization assays with wild-type and mutant CD22\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus Co-IP plus functional endocytosis assay with mutagenesis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"12646615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AP2M1 (AP50) binds the alpha1b-adrenergic receptor (alpha1b-AR) via a YXXΦ motif in its C-tail; the alpha1a-AR does not bind AP50. Phosphorylation sites in the alpha1b-AR C-tail are required for beta-arrestin interaction (the dominant endocytic trigger), while AP50 binding alone is insufficient to drive efficient internalization.\",\n      \"method\": \"Co-immunoprecipitation, beta-arrestin translocation assays, biotinylation experiments, confocal microscopy, RNA interference\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, RNAi, live imaging, biotinylation) in one study with clear mechanistic dissection\",\n      \"pmids\": [\"18523139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A conserved YXXΦ motif in HCV core protein mediates direct binding to AP2M1; this interaction recruits AP2M1 to lipid droplets, promotes core trafficking away from lipid droplets toward the trans-Golgi network, and is essential for viral assembly but not RNA replication. AAK1 and GAK kinases, which phosphorylate AP2M1 at Thr156, stimulate core–AP2M1 binding and are required for HCV assembly.\",\n      \"method\": \"Microfluidics affinity analysis, protein-fragment complementation assay, co-immunoprecipitation in infected cells, YXXΦ mutagenesis, AP2M1 siRNA knockdown, dominant-negative AP2M1 overexpression, quantitative confocal immunofluorescence, pharmacological kinase inhibition\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods including complementation assay, Co-IP, mutagenesis, dominant-negative, and KD, all in infected cells\",\n      \"pmids\": [\"22916011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"AP2M1 is identified as a downstream target of the cdk4–EZH2 axis during chemotherapy-induced senescence; AP2M1 is involved in transmission of secreted signals from senescent cells (likely via receptor endocytosis), and its upregulation by EZH2 facilitates escape from senescence in colorectal/breast cancer cells.\",\n      \"method\": \"Quantitative proteomic analysis, siRNA knockdown of EZH2, pharmacological EZH2 inhibition, cell emergence assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — proteomics identification with functional siRNA/inhibitor follow-up; mechanism proposed but partially validated\",\n      \"pmids\": [\"29415991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A recurrent de novo p.Arg170Trp variant in AP2M1 impairs the conformational activation of the AP-2 complex and significantly reduces clathrin-mediated endocytosis of transferrin in human cells and in astrocytes from AP-2μ conditional knockout mice, without affecting AP2M1 stability, expression, membrane recruitment, or localization.\",\n      \"method\": \"Whole-exome sequencing, protein dynamics modeling, functional complementation of p.Arg170Trp in human cells, transferrin endocytosis assay in AP-2μ conditional KO mouse astrocytes\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional complementation in human cells and mouse primary astrocytes with quantified endocytosis assay, supported by structural modeling; multiple orthogonal approaches\",\n      \"pmids\": [\"31104773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AP2M1 is exploited by multiple viruses (influenza A, ZIKV, HIV, MERS-CoV, SARS-CoV-2, enterovirus A71) through their conserved YXXΦ motifs; AP2M1 depletion or YXXΦ mutation causes incorrect localization of viral proteins (e.g., failure of IAV nucleoprotein nuclear import, loss of ER localization of ZIKV-NS3), suppressing viral replication. The small molecule ACA disrupts AP2M1–virus interactions and inhibits viral replication in vitro and in vivo.\",\n      \"method\": \"YxxΦ mutagenesis of viral proteins, AP2M1 siRNA depletion, pharmacological inhibition (ACA compound), immunofluorescence localization, in vitro and in vivo antiviral assays across multiple virus types\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple viruses, multiple orthogonal methods (mutagenesis, KD, pharmacology, localization), both in vitro and in vivo\",\n      \"pmids\": [\"32923629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP2M1 mediates autophagy-induced clathrin-dependent endocytosis and lysosomal degradation of the tight junction protein CLDN2 (claudin-2). AP2M1 binds CLDN2 via YXXΦ motifs (residues 67–70 and 148–151), and increased AP2M1 phosphorylation upon starvation promotes CLDN2-LC3 interaction. AP2M1 knockout prevents autophagy-induced CLDN2 degradation and enhances intestinal TJ permeability.\",\n      \"method\": \"Co-immunoprecipitation, immunolocalization, membrane fractionation, pharmacological inhibition of clathrin-mediated endocytosis, site-directed mutagenesis of CLDN2 YXXΦ motifs, AP2M1 CRISPR knockout, in vitro (cell lines), in vivo (mouse colon), ex vivo (human colon)\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, CRISPR KO, mutagenesis, fractionation, in vivo mouse, ex vivo human tissue), single lab but highly comprehensive\",\n      \"pmids\": [\"34964704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP2M1 (dpy-23 in C. elegans) supports TGF-β signaling for collagen expression by limiting caveolin-1 (CAV-1) expression; loss of dpy-23/AP2M1 upregulates cav-1 in hypodermis, which increases clathrin-independent endocytosis and reduces TGF-β receptor I (TβRI) levels, thereby reducing TGF-β signaling and collagen production.\",\n      \"method\": \"C. elegans suppressor screen, RNA-seq, cav-1 RNAi knockdown, genetic epistasis (dpy-23 × lon-2 double mutant)\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with RNA-seq and RNAi in C. elegans ortholog; indirect pathway placement for mammalian AP2M1\",\n      \"pmids\": [\"33561975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP2M1 interacts with the planar cell polarity protein Vangl2 at both its N-terminus and C-terminal Prickle-binding domain; knockdown of AP2M1 in developing cortical neurons reduces dendritic branching similarly to Vangl2 knockdown, establishing AP2M1-mediated endocytosis as necessary for dendrite morphogenesis.\",\n      \"method\": \"Yeast two-hybrid screen from mouse brain lysate, pull-down assay, shRNA knockdown in cortical neurons with dendritic branching quantification\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid confirmed by pull-down, functional KD phenotype replicated for both Vangl2 and AP2M1; single lab\",\n      \"pmids\": [\"34626136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LRRK2 directly binds and phosphorylates AP2M1 (μ2 subunit of AP-2); loss of LRRK2 reduces AP2M1 phosphorylation (required for initial clathrin-coated vesicle formation), while overexpression or gain-of-function LRRK2 G2019S inhibits CCV uncoating at later stages, blocking new CCV formation cycles. LRRK2-dependent AP2M1 phosphorylation is brain-specific and mediates dopaminergic neurodegeneration in a Drosophila PD model.\",\n      \"method\": \"Kinase binding and phosphorylation assays, analysis of SH-SY5Y cells, mouse neurons and tissues (LRRK2 KO and G2019S knockin), Drosophila genetic model of PD with neurodegeneration readout\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct kinase–substrate relationship demonstrated in multiple cell/tissue systems and confirmed functionally in vivo (Drosophila), multiple orthogonal methods\",\n      \"pmids\": [\"34315807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In a Drosophila model of AP2M1-DEE, pan-neuronal RNAi knockdown of the AP-2μ ortholog causes heat-sensitive paralysis and altered class IV dendritic arborization neuron morphology; a CRISPR-engineered p.Arg170Trp fly shows a milder seizure-resistant phenotype, suggesting the epilepsy in AP2M1-DEE may arise from broader neuronal developmental defects rather than direct synaptic dysfunction.\",\n      \"method\": \"Pan-neuronal RNAi, CRISPR knock-in of p.Arg170Trp, Drosophila behavioral assays (heat-sensitive paralysis, electrically induced seizures), dendritic morphology analysis\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR-engineered disease variant in Drosophila with multiple phenotypic readouts; single lab, ortholog model\",\n      \"pmids\": [\"41017589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In APP-overexpressing neurons, GluA2 (AMPAR subunit) undergoes enhanced endocytosis driven by increased interaction with AP2M1; a competitive peptide (G2CT) targeting the GluA2–AP2M1 interaction restores GluA2 membrane expression, improves synaptic function in vivo, and rescues cognitive deficits in 5×FAD mice without altering amyloid processing.\",\n      \"method\": \"Co-immunoprecipitation, surface biotinylation, competitive peptide (G2CT) treatment, in vivo electrophysiology, behavioral cognitive testing in 5×FAD mice, human AD brain tissue validation\",\n      \"journal\": \"Neuropharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP plus competitive peptide intervention with both in vitro and in vivo functional rescue in disease model and human tissue validation\",\n      \"pmids\": [\"41740904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NAK family kinases (AAK1, GAK, BMP2K) phosphorylate AP2M1 at Thr156, activating AP2M1 and promoting its interaction with the YXXΦ motif in PRRSV glycoprotein GP5 and the receptor CD163, which is critical for efficient PRRSV trafficking to early endosomes; disruption of this phosphorylation or blockade of the AP2M1–YXXΦ interaction significantly impairs PRRSV internalization.\",\n      \"method\": \"Genetic (siRNA/CRISPR) and pharmacological inhibition of AAK1/GAK/BMP2K, AP2M1 phosphorylation site mutagenesis (Thr156), co-immunoprecipitation, viral entry/trafficking assays\",\n      \"journal\": \"Transboundary and emerging diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct phosphorylation-site mutagenesis at Thr156, genetic and pharmacological approaches with mechanistic Co-IP, functional viral entry readout\",\n      \"pmids\": [\"41982333\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AP2M1 encodes the μ2 (medium) subunit of the clathrin adaptor protein complex AP-2 and functions as the primary cargo-recognition module: its binding domain engages YXXΦ internalization motifs in diverse transmembrane cargo proteins (CTLA-4, CD22, alpha1b-AR, CLDN2, GluA2, and viral proteins), directing them into clathrin-coated vesicles; this activity is regulated by phosphorylation of Thr156 by AAK1/GAK/LRRK2-family kinases (activating cargo binding) and by dephosphorylation during CCV uncoating (enabling coat recycling), while a pathogenic p.Arg170Trp variant impairs AP-2 conformational activation and reduces clathrin-mediated endocytosis, causing developmental and epileptic encephalopathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"AP2M1 encodes the μ2 (medium, ~50 kDa) chain of the clathrin adaptor protein complex AP-2 and serves as the principal cargo-recognition module of clathrin-mediated endocytosis [#0]. Its binding domain directly engages tyrosine-based YXXΦ internalization motifs in the cytoplasmic tails of diverse transmembrane cargo, including the immune receptors CTLA-4 [#3] and CD22 [#6], the α1b-adrenergic receptor [#7], the tight-junction protein claudin-2 [#12], and the AMPA-receptor subunit GluA2 [#17], directing these proteins into clathrin-coated vesicles. Cargo selectivity is gated by phosphorylation: for CTLA-4, phosphorylation of the YXXΦ tyrosine abolishes AP2M1 binding and instead recruits PI3K, switching the receptor between endocytic and signaling fates [#4]. AP2M1 activity is itself controlled by phosphorylation at Thr156 by NAK-family kinases (AAK1, GAK, BMP2K) and by LRRK2, which activates cargo engagement and licenses coat assembly [#1, #15, #18]; LRRK2 gain-of-function additionally impairs vesicle uncoating [#15]. Numerous viruses subvert this machinery by presenting their own YXXΦ motifs to AP2M1 to drive assembly, entry, and intracellular trafficking, including HCV core [#8], PRRSV GP5/CD163 [#18], and a broad panel of RNA viruses whose replication depends on AP2M1 [#11]. AP2M1-dependent endocytosis is required for neuronal development, supporting Vangl2-mediated dendrite morphogenesis [#14], and a recurrent de novo p.Arg170Trp variant that blocks AP-2 conformational activation and reduces clathrin-mediated endocytosis causes developmental and epileptic encephalopathy [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Established the molecular identity of AP2M1 by cloning the 50 kDa medium chain of the AP-2 coat complex, defining the protein whose function would later be dissected.\",\n      \"evidence\": \"Molecular cloning and full amino-acid sequencing from rat brain cDNA\",\n      \"pmids\": [\"3148444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sequence alone did not reveal the cargo-binding function\", \"No structural or regulatory mechanism defined at this stage\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identified Thr156 as the single regulatory phosphorylation site on AP2M1, targeted by an associated kinase activity rather than autophosphorylation, establishing post-translational control of the subunit.\",\n      \"evidence\": \"In vitro phosphorylation, tryptic peptide mapping and Edman degradation\",\n      \"pmids\": [\"8257432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the responsible kinase(s) not established\", \"Functional consequence of Thr156 phosphorylation for cargo binding not yet shown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated that AP2M1 directly recognizes YXXΦ motifs in cargo, using CTLA-4, and that phosphorylation of the cargo tyrosine acts as a binary switch between AP2M1-mediated endocytosis and PI3K signaling.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, surface expression assays, and phospho- vs non-phosphopeptide binding with Y201 mutagenesis\",\n      \"pmids\": [\"9200449\", \"9256472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of the YXXΦ recognition across cargo not yet established\", \"Structural basis of the phospho-switch not resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended the cargo-recognition model to CD22, showing AP2M1-mediated internalization is a general mechanism for receptor downregulation via tyrosine motifs.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP of α-adaptin, and internalization assays with cargo mutants\",\n      \"pmids\": [\"12646615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each tyrosine motif in vivo unclear\", \"Did not address regulation by AP2M1 phosphorylation\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showed that AP2M1 binding to cargo (α1b-AR) can be necessary but insufficient for efficient internalization, positioning AP2M1 within a multi-adaptor system that includes β-arrestin.\",\n      \"evidence\": \"Co-IP, β-arrestin translocation, biotinylation, confocal imaging and RNAi\",\n      \"pmids\": [\"18523139\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy between AP2M1 and arrestin adaptors not generalized\", \"Did not define receptor classes requiring AP2M1 alone\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked AP2M1 Thr156 phosphorylation by AAK1/GAK to active cargo engagement, demonstrated for HCV core, connecting the 1993 phospho-site to functional cargo binding.\",\n      \"evidence\": \"Affinity analysis, complementation assay, Co-IP in infected cells, mutagenesis, siRNA, dominant-negative and kinase inhibition\",\n      \"pmids\": [\"22916011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether host cargo (not viral) is similarly gated by Thr156 not directly tested here\", \"Structural mechanism of phospho-activation unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placed AP2M1 downstream of the cdk4–EZH2 axis in chemotherapy-induced senescence, implicating its endocytic activity in intercellular senescence signaling and escape.\",\n      \"evidence\": \"Quantitative proteomics, EZH2 siRNA/inhibition, and cell emergence assays\",\n      \"pmids\": [\"29415991\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct endocytic cargo mediating senescence signals not identified\", \"Mechanism inferred rather than reconstituted\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined AP2M1 as a human disease gene by showing a recurrent de novo p.Arg170Trp variant impairs AP-2 conformational activation and clathrin-mediated endocytosis, causing developmental and epileptic encephalopathy.\",\n      \"evidence\": \"Exome sequencing, dynamics modeling, complementation in human cells and transferrin endocytosis in AP-2μ conditional-KO mouse astrocytes\",\n      \"pmids\": [\"31104773\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell types and circuits driving epilepsy not defined\", \"How reduced endocytosis produces the neurological phenotype unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Generalized AP2M1 as a broadly exploited host factor across RNA viruses via their YXXΦ motifs, and showed pharmacological disruption of these interactions is antiviral.\",\n      \"evidence\": \"YXXΦ mutagenesis, siRNA depletion, ACA small-molecule inhibition, localization and in vitro/in vivo antiviral assays across multiple viruses\",\n      \"pmids\": [\"32923629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ACA also impairs essential host endocytosis not fully resolved\", \"Virus-specific dependencies on AP2M1 phosphorylation not dissected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established LRRK2 as a direct AP2M1 kinase whose phosphorylation drives coat assembly while gain-of-function blocks uncoating, linking AP2M1 regulation to dopaminergic neurodegeneration.\",\n      \"evidence\": \"Kinase binding/phosphorylation assays in SH-SY5Y cells, LRRK2-KO and G2019S mouse tissue, and a Drosophila PD model\",\n      \"pmids\": [\"34315807\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LRRK2 and NAK kinases compete or cooperate at Thr156 unclear\", \"Brain-specificity mechanism not fully explained\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Expanded AP2M1's physiological roles to tight-junction remodeling (autophagy-driven CLDN2 degradation), dendrite morphogenesis (Vangl2 endocytosis), and TGF-β signaling via the C. elegans ortholog.\",\n      \"evidence\": \"Co-IP, CRISPR KO, fractionation and in vivo/ex vivo tissue (CLDN2); yeast two-hybrid and shRNA in cortical neurons (Vangl2); suppressor screen and epistasis in C. elegans (TGF-β/CAV-1)\",\n      \"pmids\": [\"34964704\", \"34626136\", \"33561975\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Vangl2 and TGF-β roles rest on single-lab and ortholog evidence\", \"Direct cargo relationships in mammalian neurons partially inferred\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Connected AP2M1-driven cargo endocytosis to disease-relevant synaptic dysfunction, showing enhanced GluA2–AP2M1 interaction underlies AMPAR loss in Alzheimer models and that blocking it rescues cognition.\",\n      \"evidence\": \"Co-IP, surface biotinylation, competitive peptide (G2CT), in vivo electrophysiology and behavior in 5×FAD mice with human AD tissue validation\",\n      \"pmids\": [\"41740904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AP2M1 Thr156 phosphorylation modulates the GluA2 interaction not tested\", \"Generalizability beyond amyloid models unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Confirmed that NAK-family kinases (AAK1, GAK, BMP2K) activate AP2M1 via Thr156 to promote YXXΦ cargo engagement, demonstrated for PRRSV GP5/CD163 trafficking.\",\n      \"evidence\": \"siRNA/CRISPR and pharmacological kinase inhibition, Thr156 mutagenesis, Co-IP and viral entry/trafficking assays\",\n      \"pmids\": [\"41982333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous host cargo dependence on each NAK kinase not fully mapped\", \"Spatial/temporal coordination with LRRK2 phosphorylation unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How AP2M1 loss-of-function and altered cargo selectivity translate into specific neurodevelopmental and neurodegenerative phenotypes — and how Thr156 phosphorylation by competing kinases is coordinated in vivo — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking endocytic deficit to circuit-level pathology\", \"Kinase hierarchy controlling AP2M1 activation in different tissues undefined\", \"Structural mechanism of p.Arg170Trp-induced conformational defect not solved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [3, 6, 7, 12, 17]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [3, 6, 8, 11, 18]},\n      {\"term_id\": \"GO:0001618\", \"supporting_discovery_ids\": [11, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 7, 12, 17]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 3, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8, 11, 18]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 7, 13]}\n    ],\n    \"complexes\": [\"AP-2 adaptor complex\"],\n    \"partners\": [\"CTLA4\", \"CD22\", \"ADRA1B\", \"CLDN2\", \"GRIA2\", \"VANGL2\", \"LRRK2\", \"AAK1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}